{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:43:29Z","timestamp":1762033409263},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Preterm birth is an important cause of perinatal morbidity and mortality. Various biomarkers in cervicovaginal secretions related to preterm birth have been investigated, of which foetal fibronectin (fFN) shows the greatest potential because of its high negative predictive value. The immunomagnetic reduction (IMR) assay has emerged as a novel quantitative method to detect biomarkers. In this prospective case-control study, we analysed 33 samples of cervicovaginal secretions from pregnant women between 22 and 34 weeks of gestation at high risk of preterm birth. Seventeen samples were from women with term deliveries and 16 from those with preterm deliveries. The fFN concentration in each sample was measured using both an IMR assay and enzyme-linked immunosorbent assay (ELISA). The low detection limits of the IMR assay and ELISA were 0.0001\u2009ng\/mL and 0.789\u2009ng\/mL, respectively. The sensitivity and specificity of the IMR assay were 0.833 and 0.944, respectively, compared to 0.583 and 0.611 by ELISA. Our results suggest that measuring the concentration of fFN with the IMR assay is a good alternative method to accurately predict the risk of preterm birth.<\/jats:p>","DOI":"10.1038\/srep42461","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T10:34:07Z","timestamp":1487154847000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bio-functionalized magnetic nanoparticles for the immunoassay of fetal fibronectin: a feasibility study for the prediction of preterm birth"],"prefix":"10.1038","volume":"7","author":[{"given":"Chian-Huey","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie-Pein","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"BFsrep42461_CR1","unstructured":"World Health Organization. International of Diseases and Related Health Problems. 10th Revision, Geneva, Belgium (1993)."},{"key":"BFsrep42461_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","volume":"371","author":"RL Goldenberg","year":"2008","unstructured":"Goldenberg, R. L., Culhane, J. F., Iams, J. D. & Romero, R. Epidemiology and causes of preterm birth. Lancet 371, 75\u201384 (2008).","journal-title":"Lancet"},{"key":"BFsrep42461_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1515\/JPM.2005.053","volume":"33","author":"P Steer","year":"2005","unstructured":"Steer, P. The epidemiology of preterm labor\u2014A global perspective. J Perinat Med 33, 273\u2013276 (2005).","journal-title":"J Perinat Med"},{"key":"BFsrep42461_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJM199807303390506","volume":"339","author":"RL Goldenberg","year":"1999","unstructured":"Goldenberg, R. L. & Rouse, D. J. The prevention of premature birth. N Engl J Med 339, 313\u2013320 (1999).","journal-title":"N Engl J Med"},{"key":"BFsrep42461_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0378-3782(98)00052-8","volume":"53","author":"M Hack","year":"1999","unstructured":"Hack, M. & Fanaroff, A. A. Outcomes of children of extremely low birth weight and gestational age in the 1990\u2019s. Early Hum Dev 53, 193\u2013218 (1999).","journal-title":"Early Hum Dev"},{"key":"BFsrep42461_CR6","unstructured":"World Health Organization. Born Too Soon: The Global Action Report on Preterm Birth (2012)."},{"key":"BFsrep42461_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1067\/mob.2000.105411","volume":"182","author":"RL Lopez","year":"2000","unstructured":"Lopez, R. L., Francis, J. A., Garite, T. J. & Dubyak, J. M. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol 182, 1103\u20131106 (2000).","journal-title":"Am J Obstet Gynecol"},{"key":"BFsrep42461_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.325.7359.301","volume":"325","author":"H Honest","year":"2002","unstructured":"Honest, H., Bachmann, L. M., Gupta, J. K., Kleijnen, J. & Khan, K. S. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: Systematic review. BMJ 325, 1\u201310 (2002).","journal-title":"BMJ"},{"key":"BFsrep42461_CR9","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.ajog.2005.02.015","volume":"192","author":"RL Goldenberg","year":"2005","unstructured":"Goldenberg, R. L., Goepfert, A. R. & Ramsey, P. S. Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol 192, S36\u2013S46 (2005).","journal-title":"Am J Obstet Gynecol"},{"key":"BFsrep42461_CR10","first-page":"225","volume":"97","author":"GC Lu","year":"2001","unstructured":"Lu, G. C., Goldenberg, R. L., Cliver, S. P., Kreaden, U. S. & Andrews, W. W. Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women. Obstet Gynecol 97, 225\u2013228 (2001).","journal-title":"Obstet Gynecol"},{"key":"BFsrep42461_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1067\/mob.2000.107067","volume":"183","author":"AR Goepfert","year":"2000","unstructured":"Goepfert, A. R. et al. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 183, 1480\u20131483 (2000).","journal-title":"Am J Obstet Gynecol"},{"key":"BFsrep42461_CR12","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1039\/C6CC01238H","volume":"52","author":"CC Chang","year":"2016","unstructured":"Chang, C. C., Chen, C. P., Chen, C. Y. & Lin, C. W. DNA base-stacking assay utilizing catalytic hairpin assembly-induced gold nanoparticle aggregation for colorimetric protein sensing. Chem Commun 52, 4167\u20134170 (2016).","journal-title":"Chem Commun"},{"key":"BFsrep42461_CR13","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.3390\/s120403879","volume":"12","author":"CY Chen","year":"2012","unstructured":"Chen, C. Y., Chang, C. C., Yu, C. & Lin, C. W. Clinical application of surface plasmon resonance-based biosensors for fetal fibronectin detection. Sensors 12, 3879\u20133890 (2012).","journal-title":"Sensors"},{"key":"BFsrep42461_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4015\/S1016237211002621","volume":"23","author":"CY Chen","year":"2011","unstructured":"Chen, C. Y., Chang, C. C., Yu, C., Yang, S. Y. & Lin, C. W. Immunomagnetic reduction for fetal fibronectin detection-a novel method to detect the preterm biomarker. Biomed Eng App Bas C 23, 273\u2013278 (2011).","journal-title":"Biomed Eng App Bas C"},{"key":"BFsrep42461_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jviromet.2009.11.016","volume":"164","author":"SY Yang","year":"2010","unstructured":"Yang, S. Y. et al. Magnetically enhanced high-specificity virus detection using bioactivated magnetic nanoparticles with antibodies as labeling markers. J Virol Methods 164, 14\u201318 (2010).","journal-title":"J Virol Methods"},{"key":"BFsrep42461_CR16","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.2147\/IJN.S81201","volume":"10","author":"CY Chen","year":"2015","unstructured":"Chen, C. Y., Hwu, Y. M., Chen, C. P. & Chang, C. C. Quantitative analysis of total \u03b2-subunit of human chorionic gonadotropin concentration in urine by immunomagnetic reduction to assist in the diagnosis of ectopic pregnancy. Int J Nanomedicine 10, 2475\u20132483 (2015).","journal-title":"Int J Nanomedicine"},{"key":"BFsrep42461_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cca.2014.09.023","volume":"438","author":"CY Chen","year":"2015","unstructured":"Chen, C. Y., Chang, C. C. & Lin, C. W. Clinical application of immunomagnetic reduction for quantitative measurement of insulin-like growth factor binding protein-1 in the prediction of pregnant women with preterm premature rupture of membranes. Clin Chim Acta 438, 337\u2013341 (2015).","journal-title":"Clin Chim Acta"},{"key":"BFsrep42461_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jmmm.2004.05.022","volume":"283","author":"WQ Jiang","year":"2004","unstructured":"Jiang, W. Q. et al. Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible. J Magn Magn Mater 283, 210\u2013214 (2004).","journal-title":"J Magn Magn Mater"},{"issue":"8","key":"BFsrep42461_CR19","doi-asserted-by":"publisher","first-page":"e0135290","DOI":"10.1371\/journal.pone.0135290","volume":"10","author":"Kuen-Lin Chen","year":"2015","unstructured":"Chen, K. L. et al. Magnetic clustering effect during the association of biofunctionalized magnetic nanoparticles with biomarkers. Plos One 10, e0135290-1\u201312 (2015).","journal-title":"PLOS ONE"},{"key":"BFsrep42461_CR20","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/j.jmmm.2008.05.048","volume":"320","author":"SY Yang","year":"2008","unstructured":"Yang, S. Y. et al. Dual immobilization and magnetic manipulation of magnetic nanoparticles. J Magn Magn Mater 320, 2688\u20132691 (2008).","journal-title":"J Magn Magn Mater"},{"key":"BFsrep42461_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1109\/TNB.2013.2240009","volume":"12","author":"SY Yang","year":"2013","unstructured":"Yang, S. Y. et al. Experimental study on low-detection limit for immunomagnetic reduction assays by manipulating reagent entities. IEEE Trans Nanobioscience 12, 65\u201368 (2013).","journal-title":"IEEE Trans Nanobioscience"},{"key":"BFsrep42461_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1504\/IJNT.2011.044435","volume":"8","author":"V Sreeja","year":"2011","unstructured":"Sreeja, V. & Joy, P. A. Effect of inter-particle interactions on the magnetic properties of magnetite nanoparticles after coating with dextran. Int J Nanotech 8, 907\u2013915 (2011).","journal-title":"Int J Nanotech"},{"key":"BFsrep42461_CR23","doi-asserted-by":"crossref","unstructured":"Yang, S. Y. et al. Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles. J Nanobiotechnol 14, 41-1-8 (2016).","DOI":"10.1186\/s12951-016-0198-5"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42461","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:12:16Z","timestamp":1671826336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,15]]}},"alternative-id":["BFsrep42461"],"URL":"https:\/\/doi.org\/10.1038\/srep42461","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"assertion":[{"value":"16 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42461"}}